Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug to treat brain injuries such as concussion and stroke.

UT Health Science Center San Antonio spinoff company gains funding for trial in people. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Oct. 4, 2021) — Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug […]

Sudha Seshadri, MD, professor of neurology and the founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, has a superb reputation in both science and clinical care and is a recognized thought leader in Alzheimer’s disease.